Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril (Q28196378)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: April 2006)

Language	Label	Description	Also known as
English	Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril	scientific article (publication date: April 2006)

Statements

scholarly article

0 references

Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril (English)

0 references

1 reference

based on heuristic

inferred from title

platelet aggregation

1 reference

based on heuristic

inferred from title

1

object named as

Dirk Skowasch

0 references

author name string

Achim Viktor

2

0 references

Melanie Schneider-Schmitt

3

0 references

Berndt Lüderitz

4

0 references

Georg Nickenig

5

0 references

Gerhard Bauriedel

6

0 references

language of work or name

0 references

publication date

April 2006

0 references

Clinical Research in Cardiology

0 references

95

0 references

4

0 references

212-6

0 references

Angiotensin-Converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in Monocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00392-006-0363-1

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Acute Infarction Ramipril Efficacy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Captopril administration reduces thrombus formation and surface expression of platelet glycoprotein IIb/IIa in early postmyocardial infarction stage

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II type 1 receptor expression in human coronary arteries with variable degrees of atherosclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term safety of an early ACE-inhibitor treatment of patients with acute myocardial infarction: results of the 3 year follow-up period on 696 Swiss patients randomized to the ISIS-4 trial. ISIS-Switzerland Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACE inhibitors in heart failure: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collabor

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients with documented atherosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of ramipril versus other angiotensin-converting enzyme inhibitors on outcome of unselected patients with ST-elevation acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/16598590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00392-006-0363-1

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28196378&oldid=2177500429"